Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.

Movement disorders : official journal of the Movement Disorder Society - 1 Jun 2021

Galper Jasmin, Balwani Manisha, Fahn Stanley, Waters Cheryl, Krohn Lynne, Gan-Or Ziv, Dzamko Nicolas, Alcalay Roy N

Abstract excerpt

BACKGROUND: Homozygous and compound heterozygous variants in glucocerebrosidase (GBA) can cause Gaucher disease (GD), whereas heterozygous variants increase the risk of developing Parkinson's disease (PD). GD patients display altered peripheral immune proteins. However, it is unknown if these are altered in GBA carriers with PD. OBJECTIVES: To determine whether plasma cytokines and immune biomarkers associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Carbohydrate Chemistry and Synthesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Gaucher Disease

Share to Glucosylceramidase

Share to Lysosomal Storage Disorders Research

Share to Mutation

Share to Parkinson Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 33570220
DOI: 10.1002/mds.28525
PMCID: PMC8248172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.PMID 33570220Read ↗

Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.Semantic proximity Read ↗

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.Semantic proximity Read ↗

Transcriptome deregulation of peripheral monocytes in <i>GBA</i>-related Parkinson’s diseaseSemantic proximity Read ↗

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.Semantic proximity Read ↗

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.Semantic proximity Read ↗

Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers.Semantic proximity Read ↗

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.Semantic proximity Read ↗

Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease.Semantic proximity Read ↗

Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?Semantic proximity Read ↗

LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population.Semantic proximity Read ↗

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.Semantic proximity Read ↗

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.